Therapeutic Effect of Avocatin B in Avocados Toward Acute Myeloid Leukemia
DOI:
https://doi.org/10.55175/cdk.v45i11.695Keywords:
Acute myeloid leukemia, Avocatin B, fatty acid oxidation, Leukemic Stem CellsAbstract
Acute myeloid leukemia is the abnormal division of immature myeloid precursor cells in the bone marrow affecting mostly older people. Till date, there are no potent treatments due to the fact that it cannot target leukemic stem cells which are responsible for relapse and initiation of leukemia. Current treatments can also pose side effects that might to be too harsh for older people. Avocatin B is a lipid derived from avocado that can be a novel potent drug to replace or go along with the current therapies. Avocatin B is able to induce leukemic cell death and their stem cells while leaving normal cells unharmed. Their mechanisms of actions include inhibiting fatty acid oxidation which causes reactive oxygen species mediated apoptosis and lipotoxicity. Their selectivity towards leukemic cells over normal cells are due to the fact that they are able to target leukemic mitochondria which are different from the normal cells’ mitochondria in terms of their metabolic pathways.
Leukemia myeloid akut merupakan sel precursor myeloid dalam sumsum tulang dewasa yang abnormal. Hingga saat ini, belum ada terapi yang tepat untuk leukemia myeloid akut. Avocatin B adalah lipid yang berasal dari alpukat, dapat menjadi obat baru atau digabungkan dengan terapi saat ini. Avocatin B mampu menginduksi kematian sel leukemia dan sel induknya. Mekanisme Avocation B meliputi penghambatan oksidasi asam lemak yang menyebabkan oksigen reaktif memediasi apoptosis dan lipotoksisitas. Selektivitas avocatin B terhadap sel-sel leukemia karena dapat menarget mitokondria penderita leukemia yang berbeda jalur metabolisme dari mitokondria sel-sel normal.
Downloads
References
Karp J. Acute Myeloid Leukemia. Baltimore: Leukemia & Lymphoma Society; 2011
American Cancer Society [Internet]. Atlanta: American Cancer Society;2014 [ Cited 2016 March 23]. Available from http://www.cancer.org/cancer/leukemiaacutemyeloidaml/detailedguide/leukemia-acute-myeloid-myelogenous-key-statistics
Lee EA. Evaluating the anti-leukemia activity of Avocatin B. Waterloo: University of Waterloo; 2014
Lee EA, Angka L, Rota SG, Hanlon T, Mitchell A, Hurren R, et al. Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell Death. Cancer Research,Cancer Res. 2015 Jun: 75(12): 2478-88
Yan B, Dong L, Neuzil J. Mitochondria: An intriguing target for killing tumour –initiating cells. Mitochondrion. 2015 Dec: 26: 86-93.
Carracedo A, Cantley LC, Pandolfi PP. Cancer metabolism: fatty acid oxidation in the limelight. Nature Reviews Cancer, Nat Rev Cancer. 2013 Feb: 13(4):227-32
Samudio I, Konopleva M. Targeting leukemia’s “Fatty tooth”. Blood. 2015 Oct:126(16): 1874-5.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 https://creativecommons.org/licenses/by-nc/4.0/
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.